|
|
| (788 גרסאות ביניים של 2 משתמשים אינן מוצגות) |
| שורה 1: |
שורה 1: |
| − | מפתח קודי ATC
| + | #הפניה [[t:קוד ATC code - ATC]] |
| − | | |
| − | | |
| − | ==גישה מהירה [[#עוגןA|A]] / [[#עוגןB|B]] / [[#עוגןC|C]] / [[#עוגןD|D]] / [[#עוגןG|G]] / [[#עוגןH|H]] / [[#עוגןJ|J]] / [[#עוגןL|L]] / [[#עוגןM|M]] / [[#עוגןN|N]] / [[#עוגןP|P]] / [[#עוגןR|R]] / [[#עוגןS|S]] / [[#עוגןV|V]] ==
| |
| − | | |
| − | * הטבלא ניתנת למיון לפי כל אחת מהעמודות
| |
| − | | |
| − | {|border="1" dir="ltr" cellpadding="4" class="sortable"
| |
| − | |1st level
| |
| − | |2nd level
| |
| − | |3rd level
| |
| − | |4th level
| |
| − | |5th level
| |
| − | |Contents
| |
| − | |-
| |
| − | |{{עוגן2|עוגןA}}{{כ}}A
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Alimentary tract and metabolism-A]]
| |
| − | |-
| |
| − | |
| |
| − | |A01
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Stomatological preparations]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |A01A
| |
| − | |
| |
| − | |
| |
| − | |[[Stomatological preparations]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |A01AA
| |
| − | |
| |
| − | |[[Caries prophylactic agents]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A01AA01
| |
| − | | [[Sodium fluoride]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A01AA02
| |
| − | |[[Sodium monofluorophosphate]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A01AA03
| |
| − | |[[Olaflur]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |A01AA04
| |
| − | |[[Stannous fluoride]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A01AA30
| |
| − | |[[Combinations]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |A01AA51
| |
| − | |[[Sodium fluoride, combinations]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |A01AB
| |
| − | |
| |
| − | |[[Anti-infectives and antiseptics for local oral treatment]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |A01AB02
| |
| − | |[[Hydrogen peroxide]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |A01AB03
| |
| − | |[[Chlorhexidine]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |A01AB04
| |
| − | |[[Amphotericin B]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |A01AB05
| |
| − | |[[Polynoxylin]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |A01AB06
| |
| − | |[[Domiphen]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |A01AB07
| |
| − | |[[Oxyquinoline]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |A01AB08
| |
| − | |[[Neomycin]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |A01AB09
| |
| − | |[[Miconazole]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |A01AB10
| |
| − | |[[Natamycin]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |A01AB11
| |
| − | | [[Various]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A01AB12
| |
| − | |[[Hexetidine]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A01AB13
| |
| − | |[[Tetracycline]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A01AB14
| |
| − | | [[Benzoxonium chloride]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A01AB15
| |
| − | | [[Tibezonium iodide]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A01AB16
| |
| − | |[[Mepartricin]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A01AB17
| |
| − | |[[Metronidazole]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A01AB18
| |
| − | | [[Clotrimazole]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A01AB19
| |
| − | | [[Sodium perborate]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A01AB21
| |
| − | | [[Chlortetracycline]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |A01AB22
| |
| − | | [[Doxycycline]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |A01AB23
| |
| − | | [[Minocycline]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |A01AC
| |
| − | |
| |
| − | | [[Corticosteroids for local oral treatment]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |A01AC01
| |
| − | | [[Triamcinolone]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A01AC02
| |
| − | | [[Dexamethasone]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A01AC03
| |
| − | | [[Hydrocortisone]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A01AC54
| |
| − | | [[Prednisolone, combinations]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A01AD
| |
| − | |
| |
| − | |[[Other agents for local oral treatment]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A01AD01
| |
| − | | [[Epinephrine]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A01AD02
| |
| − | | [[Benzydamine]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A01AD05
| |
| − | | [[Acetylsalicylic acid]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A01AD06
| |
| − | | [[Adrenalone]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A01AD07
| |
| − | | [[Amlexanox]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A01AD08
| |
| − | | [[Becaplermin]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A01AD11
| |
| − | | [[Various]]
| |
| − | |-
| |
| − | |
| |
| − | |A02
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Drugs for acid related disorders]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |A02A
| |
| − | |
| |
| − | |
| |
| − | | [[Antacids]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |A02AA
| |
| − | |
| |
| − | | [[Magnesium compounds]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02AA01
| |
| − | | [[Magnesium carbonate]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02AA02
| |
| − | | [[Magnesium oxide]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02AA03
| |
| − | | [[Magnesium peroxide]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02AA04
| |
| − | | [[Magnesium hydroxide]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02AA05
| |
| − | | [[Magnesium silicate]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02AA10
| |
| − | | [[Combinations]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |A02AB
| |
| − | |
| |
| − | | [[Aluminium compounds]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02AB01
| |
| − | | [[Aluminium hydroxide]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02AB02
| |
| − | | [[Algeldrate]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02AB03
| |
| − | | [[Aluminium phosphate]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02AB04
| |
| − | | [[Dihydroxialumini sodium carbonate]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02AB05
| |
| − | | [[Aluminium acetoacetate]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02AB06
| |
| − | | [[Aloglutamol]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02AB07
| |
| − | | [[Aluminium glycinate]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02AB10
| |
| − | | [[Combinations]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |A02AC
| |
| − | |
| |
| − | |[[Calcium compounds]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02AC01
| |
| − | | [[Calcium carbonate]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |A02AC02
| |
| − | | [[Calcium silicate]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02AC10
| |
| − | | [[Combinations]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |A02AD
| |
| − | |
| |
| − | | [[Combinations and complexes of aluminium, calcium and magnesium compounds]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |A02AD01
| |
| − | | [[Ordinary salt combinations]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02AD02
| |
| − | | [[Magaldrate]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02AD03
| |
| − | | [[Almagate]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02AD04
| |
| − | | [[Hydrotalcite]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02AD05
| |
| − | | [[Almasilate]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |A02AF
| |
| − | |
| |
| − | | [[Antacids with antiflatulents]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02AF01
| |
| − | | [[Magaldrate and antiflatulents]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02AF02
| |
| − | | [[Ordinary salt combinations and antiflatulents]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02AG
| |
| − | |
| |
| − | | [[Antacids with antispasmodics]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | A02AH
| |
| − | |
| |
| − | | [[Antacids with sodium bicarbonate]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |A02AX
| |
| − | |
| |
| − | | [[Antacids, other combinations]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |A02B
| |
| − | |
| |
| − | |
| |
| − | | [[Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |A02BA
| |
| − | |
| |
| − | | [[H2-receptor antagonists]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |A02BA01
| |
| − | | [[Cimetidine]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BA02
| |
| − | | [[Ranitidine]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BA03
| |
| − | | [[Famotidine]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BA04
| |
| − | | [[Nizatidine]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BA05
| |
| − | | [[Niperotidine]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BA06
| |
| − | | [[Roxatidine]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BA07
| |
| − | | [[Ranitidine bismuth citrate]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BA08
| |
| − | | [[Lafutidine]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BA51
| |
| − | | [[Cimetidine, combinations]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BA53
| |
| − | | [[Famotidine, combinations]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |A02BB
| |
| − | |
| |
| − | | [[Prostaglandins]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BB01
| |
| − | | [[Misoprostol]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BB02
| |
| − | | [[Enprostil]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |A02BC
| |
| − | |
| |
| − | | [[Proton pump inhibitors]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BC01
| |
| − | | [[Omeprazole]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BC02
| |
| − | | [[Pantoprazole]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BC03
| |
| − | | [[Lansoprazole]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BC04
| |
| − | | [[Rabeprazole]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BC05
| |
| − | | [[Esomeprazole]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BC06
| |
| − | | [[Dexlansoprazole]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |A02BD
| |
| − | |
| |
| − | | [[Combinations for eradication of Helicobacter pylori]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BD01
| |
| − | | [[Omeprazole, amoxicillin and metronidazole]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BD02
| |
| − | | [[Lansoprazole, tetracycline and metronidazole]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BD03
| |
| − | | [[Lansoprazole, amoxicillin and metronidazole]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BD04
| |
| − | | [[Pantoprazole, amoxicillin and clarithromycin]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BD05
| |
| − | | [[Omeprazole, amoxicillin and clarithromycin]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BD06
| |
| − | | [[Esomeprazole, amoxicillin and clarithromycin]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BD07
| |
| − | | [[Lansoprazole, amoxicillin and clarithromycin]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BD08
| |
| − | | [[Bismuth subcitrate, tetracycline and metronidazole]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |A02BX
| |
| − | |
| |
| − | | [[Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BX01
| |
| − | | [[Carbenoxolone]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BX02
| |
| − | | [[Sucralfate]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BX03
| |
| − | | [[Pirenzepine]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BX04
| |
| − | | [[Methiosulfonium chloride]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BX05
| |
| − | | [[Bismuth subcitrate]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BX06
| |
| − | | [[Proglumide]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BX07
| |
| − | | [[Gefarnate]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BX08
| |
| − | | [[Sulglicotide]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BX09
| |
| − | | [[Acetoxolone]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BX10
| |
| − | | [[Zolimidine]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BX11
| |
| − | | [[Troxipide]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BX12
| |
| − | | [[Bismuth subnitrate]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BX13
| |
| − | | [[Alginic acid]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BX51
| |
| − | | [[Carbenoxolone, combinations excluding psycholeptics]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BX71
| |
| − | | [[Carbenoxolone, combinations with psycholeptics]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | A02BX77
| |
| − | | [[Gefarnate, combinations with psycholeptics]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |A02X
| |
| − | |
| |
| − | |
| |
| − | | [[Other drugs for acid related disorders]]
| |
| − | |-
| |
| − | |
| |
| − | |A03
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Drugs for functional gastrointestinal disorders]]
| |
| − | |-
| |
| − | |
| |
| − | |A04
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Antiemetics and antinauseants]]
| |
| − | |-
| |
| − | |
| |
| − | |A05
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Bile and liver therapy]]
| |
| − | |-
| |
| − | |
| |
| − | |A06
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Drugs for constipation]]
| |
| − | |-
| |
| − | |
| |
| − | |A07
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Antidiarrheals, intestinal anti-inflammatory/anti-infective agents]]
| |
| − | |-
| |
| − | |
| |
| − | |A08
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Antiobesity preparations, excluding diet products]]
| |
| − | |-
| |
| − | |
| |
| − | |A09
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Digestives,including enzymes]]
| |
| − | |-
| |
| − | |
| |
| − | |A10
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Drugs used in diabetes]]
| |
| − | |-
| |
| − | |
| |
| − | |A11
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Vitamins]]
| |
| − | |-
| |
| − | |
| |
| − | |A12
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Mineral supplements]]
| |
| − | |-
| |
| − | |
| |
| − | |A13
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Tonics]]
| |
| − | |-
| |
| − | |
| |
| − | |A14
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Anabolic agents for systemic use]]
| |
| − | |-
| |
| − | |
| |
| − | |A15
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Appetite stimulants]]
| |
| − | |-
| |
| − | |
| |
| − | |A16
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Other alimentary tract and metabolism products]]
| |
| − | |-
| |
| − | |{{עוגן2|עוגןB}}{{כ}}B
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Blood and blood forming organs]]
| |
| − | |-
| |
| − | |{{עוגן2|עוגןC}}{{כ}}C
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Cardiovascular system]]
| |
| − | |-
| |
| − | |
| |
| − | |C01
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Cardiac therapy]]
| |
| − | |-
| |
| − | |
| |
| − | |C02
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Antihypertensives]]
| |
| − | |-
| |
| − | |
| |
| − | |C03
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Diuretics]]
| |
| − | |-
| |
| − | |
| |
| − | |C04
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Peripheral vasodilators]]
| |
| − | |-
| |
| − | |
| |
| − | |C05
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Vasoprotectives]]
| |
| − | |-
| |
| − | |
| |
| − | |C07
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Beta blocking agents]]
| |
| − | |-
| |
| − | |
| |
| − | |C08
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Calcium channel blockers]]
| |
| − | |-
| |
| − | |
| |
| − | |C09
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Agents acting on the renin-angiotensin system]]
| |
| − | |-
| |
| − | |
| |
| − | |C10
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Lipid modifying agents]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |C10A
| |
| − | |
| |
| − | |
| |
| − | |[[Lipid modifying agents, plain]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |C10AA
| |
| − | |
| |
| − | |[[HMG CoA reductase inhibitors]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |C10AB
| |
| − | |
| |
| − | |[[Fibrates]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |C10AC
| |
| − | |
| |
| − | |[[Bile acid sequestrants]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | C10AC01
| |
| − | |[[Colestyramine]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |C10AC02
| |
| − | |[[Colestipol]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | C10AC03
| |
| − | |[[Colextran]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |C10AC04
| |
| − | |[[Colesevelam]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |C10AD
| |
| − | |
| |
| − | |[[Nicotinic acid and derivatives]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |C10AX
| |
| − | |
| |
| − | |[[Other lipid modifying agents]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |C10B
| |
| − | |
| |
| − | |
| |
| − | |[[Lipid modifying agents, combinations]]
| |
| − | |-
| |
| − | |{{עוגן2|עוגןD}}{{כ}}D
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Dermatologicals]]
| |
| − | |-
| |
| − | |{{עוגן2|עוגןG}}{{כ}}G
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Genito-urinary system and sex hormones]]
| |
| − | |-
| |
| − | |{{עוגן2|עוגןH}}{{כ}}H
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Systemic hormonal preparations, excluding sex hormones and insulins]]
| |
| − | |-
| |
| − | |{{עוגן2|עוגןJ}}{{כ}}J
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Antiinfectives for systemic use]]
| |
| − | |-
| |
| − | |
| |
| − | |J01
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Antibacterials for systemic use]]
| |
| − | |-
| |
| − | |
| |
| − | |J02
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Antimycotics for systemic use]]
| |
| − | |-
| |
| − | |
| |
| − | |J04
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Antimycobacterials]]
| |
| − | |-
| |
| − | |
| |
| − | |J05
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Antivirals for systemic use]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |J05A
| |
| − | |
| |
| − | |
| |
| − | |[[Direct acting antiviral drugs]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J05AA
| |
| − | |
| |
| − | |[[Thiosemicarbazones]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J05AB
| |
| − | |
| |
| − | |[[Nucleosides and nucleotides excluding reverse transcriptase inhibitors]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J05AC
| |
| − | |
| |
| − | |[[Cyclic amines]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J05AD
| |
| − | |
| |
| − | |[[Phosphonic acid derivatives]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J05AE
| |
| − | |
| |
| − | |[[Protease inhibitors]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J05AF
| |
| − | |
| |
| − | |[[Nucleoside and nucleotide reverse transcriptase inhibitors]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J05AF01
| |
| − | | [[Zidovudine]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J05AF02
| |
| − | | [[Didanosine]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J05AF03
| |
| − | | [[Zalcitabine]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J05AF04
| |
| − | | [[Stavudine]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J05AF05
| |
| − | | [[Lamivudine]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J05AF06
| |
| − | | [[Abacavir]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J05AF07
| |
| − | | Tenofovir [[disoproxil]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J05AF08
| |
| − | | Adefovir [[dipivoxil]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J05AF09
| |
| − | | [[Emtricitabine]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J05AF10
| |
| − | | [[Entecavir]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J05AF11
| |
| − | | [[Telbivudine]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J05AF12
| |
| − | | [[Clevudine]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J05AG
| |
| − | |
| |
| − | |[[Non-nucleoside reverse transcriptase inhibitors]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J05AH
| |
| − | |
| |
| − | |[[Neuraminidase inhibitors]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J05AR
| |
| − | |
| |
| − | |[[Antivirals for treatment of HIV infections, combinations]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J05AX
| |
| − | |
| |
| − | |[[Other antivirals]]
| |
| − | |-
| |
| − | |
| |
| − | |J06
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Immune sera and immunoglobulins]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |J06A
| |
| − | |
| |
| − | |
| |
| − | | [[Immune sera]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J06AA
| |
| − | |
| |
| − | | [[Immune sera]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J06AA01
| |
| − | | [[Diphtheria antitoxin]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | J06AA02
| |
| − | | [[Tetanus antitoxin]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J06AA03
| |
| − | | [[Snake venom antiserum]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | J06AA04
| |
| − | | [[Botulinum antitoxin]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J06AA05
| |
| − | | [[Gas-gangrene sera]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | J06AA06
| |
| − | | [[Rabies serum]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |J06B
| |
| − | |
| |
| − | |
| |
| − | | [[Immunoglobulins]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J06BA
| |
| − | |
| |
| − | |[[Immunoglobulins, normal human]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J06BA01
| |
| − | |[[Immunoglobulins, normal human, for extravascular administration]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | J06BA02
| |
| − | |[[Immunoglobulins, normal human, for intravascular administration]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J06BB
| |
| − | |
| |
| − | |[[Specific immunoglobulins]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J06BB01
| |
| − | |[[Anti-D (rh) immunoglobulin]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J06BB02
| |
| − | | [[Tetanus immunoglobulin]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J06BB03
| |
| − | | [[Varicella/zoster immunoglobulin]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J06BB04
| |
| − | | [[Hepatitis B immunoglobulin]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J06BB05
| |
| − | | [[Rabies immunoglobulin]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | J06BB06
| |
| − | | [[Rubella immunoglobulin]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | J06BB07
| |
| − | | [[Vaccinia immunoglobulin]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J06BB08
| |
| − | | [[Staphylococcus immunoglobulin]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | J06BB09
| |
| − | | [[Cytomegalovirus immunoglobulin]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J06BB10
| |
| − | | [[Diphtheria immunoglobulin]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J06BB11
| |
| − | | [[Hepatitis A immunoglobulin]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J06BB12
| |
| − | | [[Encephalitis, tick borne immunoglobulin]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J06BB13
| |
| − | | [[Pertussis immunoglobulin]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J06BB14
| |
| − | |[[Morbilli immunoglobulin]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J06BB15
| |
| − | | [[Parotitis immunoglobulin]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J06BB16
| |
| − | | [[Palivizumab]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | J06BB17
| |
| − | | [[Motavizumab]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J06BB30
| |
| − | | [[Combinations]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J06BC
| |
| − | |
| |
| − | | [[Other immunoglobulins]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |J06BC01
| |
| − | | [[Nebacumab]]
| |
| − | |-
| |
| − | |{{עוגן2|עוגןL}}{{כ}}L
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Antineoplastic and immunomodulating agents]]
| |
| − | |-
| |
| − | |
| |
| − | |L01
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Antineoplastic agents]]
| |
| − | |-
| |
| − | |
| |
| − | |L02
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Endocrine therapy]]
| |
| − | |-
| |
| − | |
| |
| − | |L03
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Immunostimulants]]
| |
| − | |-
| |
| − | |
| |
| − | |L04
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Immunosuppressants]]
| |
| − | |-
| |
| − | |{{עוגן2|עוגןM}}{{כ}}M
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Musculo-skeletal system]]
| |
| − | |-
| |
| − | |
| |
| − | |M01
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Anti-inflammatory and antirheumatic products]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |M01A
| |
| − | |
| |
| − | |
| |
| − | |[[Anti-inflammatory and antirheumatic products, non-steroids]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |M01AA
| |
| − | |
| |
| − | |[[Butylpyrazolidines]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |M01AB
| |
| − | |
| |
| − | |[[Acetic acid derivatives and related substances]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | M01AB01
| |
| − | | [[Indometacin]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | M01AB02
| |
| − | | [[Sulindac]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | M01AB03
| |
| − | | [[Tolmetin]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | M01AB04
| |
| − | | [[Zomepirac]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | M01AB05
| |
| − | | [[Diclofenac]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | M01AB06
| |
| − | | [[Alclofenac]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | M01AB07
| |
| − | | [[Bumadizone]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | M01AB08
| |
| − | | [[Etodolac]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | M01AB09
| |
| − | | [[Lonazolac]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | M01AB10
| |
| − | | [[Fentiazac]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | M01AB11
| |
| − | | [[Acemetacin]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | M01AB12
| |
| − | | [[Difenpiramide]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | M01AB13
| |
| − | | [[Oxametacin]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | M01AB14
| |
| − | | [[Proglumetacin]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | M01AB15
| |
| − | | [[Ketorolac]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | M01AB16
| |
| − | | [[Aceclofenac]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | M01AB17
| |
| − | | [[Bufexamac]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | M01AB51
| |
| − | | [[Indometacin, combinations]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | M01AB55
| |
| − | | [[Diclofenac, combinations]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |M01AC
| |
| − | |
| |
| − | |[[Oxicams]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |M01AE
| |
| − | |
| |
| − | |[[Propionic acid derivatives]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |M01AG
| |
| − | |
| |
| − | |[[Fenamates]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |M01AH
| |
| − | |
| |
| − | |[[Coxibs]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |M01AX
| |
| − | |
| |
| − | |[[Other anti-inflammatory and antirheumatic agents, non-steroids]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |M01B
| |
| − | |
| |
| − | |
| |
| − | |[[Anti-inflammatory/antirheumatic agents in combination]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |M01C
| |
| − | |
| |
| − | |
| |
| − | |[[Specific antirheumatic agents]]
| |
| − | |-
| |
| − | |
| |
| − | |M02
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Topical products for joint and muscular pain]]
| |
| − | |-
| |
| − | |
| |
| − | |M03
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Muscle relaxants]]
| |
| − | |-
| |
| − | |
| |
| − | |M04
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Antigout preparations]]
| |
| − | |-
| |
| − | |
| |
| − | |M05
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Drugs for treatment of bone diseases]]
| |
| − | |-
| |
| − | |
| |
| − | |M09
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Other drugs for disorders of the musculo-skeletal system]]
| |
| − | |-
| |
| − | |{{עוגן2|עוגןN}}{{כ}}N
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Nervous system]]
| |
| − | |-
| |
| − | |
| |
| − | |N01
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | [[Anesthetics]]
| |
| − | |-
| |
| − | |
| |
| − | |N02
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | [[Analgesics]]
| |
| − | |-
| |
| − | |
| |
| − | |N03
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | [[Antiepileptics]]
| |
| − | |-
| |
| − | |
| |
| − | |N04
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Anti-parkinson drugs]]
| |
| − | |-
| |
| − | |
| |
| − | |N05
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | [[Psycholeptics]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |N05A
| |
| − | |
| |
| − | |
| |
| − | | [[Antipsychotics]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |N05AA
| |
| − | |
| |
| − | |[[Phenothiazines with aliphatic side-chain]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |N05AB
| |
| − | |
| |
| − | |[[Phenothiazines with piperazine structure]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |N05AC
| |
| − | |
| |
| − | |[[Phenothiazines with piperidine structure]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |N05AD
| |
| − | |
| |
| − | |[[Butyrophenone derivatives]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |N05AE
| |
| − | |
| |
| − | |[[Indole derivatives]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |N05AF
| |
| − | |
| |
| − | |[[Thioxanthene derivative]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |N05AG
| |
| − | |
| |
| − | |[[Diphenylbutylpiperidine derivatives]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |N05AH
| |
| − | |
| |
| − | |[[Diazepines, oxazepines, thiazepines and oxepines]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |N05AL
| |
| − | |
| |
| − | |[[Benzamides]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |N05AN
| |
| − | |
| |
| − | |[[Lithium]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |N05AX
| |
| − | |
| |
| − | |[[Other antipsychotics]]
| |
| − | |-
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | N05AX07
| |
| − | |[[Prothipendyl]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |N05AX08
| |
| − | |[[Risperidone]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |N05AX10
| |
| − | |[[Mosapramine]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |N05AX11
| |
| − | |[[Zotepine]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |N05AX12
| |
| − | |[[Aripiprazole]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |N05AX13
| |
| − | |[[Paliperidone]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |N05AX14
| |
| − | |[[Iloperidone]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |N05B
| |
| − | |
| |
| − | |
| |
| − | | [[Anxiolytics]]
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |N05C
| |
| − | |
| |
| − | |
| |
| − | | [[Hypnotics and sedatives]]
| |
| − | |-
| |
| − | |
| |
| − | |N06
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | [[Psychoanaleptics]]
| |
| − | |-
| |
| − | |
| |
| − | |N07
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | | [[Other nervous system drugs]]
| |
| − | |-
| |
| − | |{{עוגן2|עוגןP}}{{כ}}P
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Antiparasitic products, insecticides and repellents]]
| |
| − | |-
| |
| − | |{{עוגן2|עוגןR}}{{כ}}R
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Respiratory system]]
| |
| − | |-
| |
| − | |{{עוגן2|עוגןS}}{{כ}}S
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Sensory organs]]
| |
| − | |-
| |
| − | |{{עוגן2|עוגןV}}{{כ}}V
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |[[Various]]
| |
| − | |}
| |
| − | | |
| − | ==ביבליוגרפיה==
| |
| − | | |
| − | * [http://www.whocc.no/atc_ddd_index/ ATC/DDD Index 2013]
| |
| − | | |
| − | [[קטגוריה:Anatomical Therapeutic Chemical (ATC) classification]]
| |
כניסה 
עקבו אחרינו בפייסבוק